Clinical Trial

First In Human Study for Small to Medium-sized Abdominal Aortic Aneurysm (AAA)

Study acronym: AAA
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This is a first in human study to evaluate the safety and clinical utility of an investigational medical device called the Nectero EAST System to treat Abdominal Aortic Aneurysms or AAA.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2021-11-12; most recent amendment 2025-12-12.
Status change: Recruiting → Active, Not Recruiting 2024-01-02
Trial Details
NCT Number NCT05133492
Lead Sponsor Nectero Medical, Inc.
Conditions Abdominal Aortic Aneurysm, AAA, Dilation Aorta
Enrollment 46 participants
Start Date 2019-06-24
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-12-16